NCT04119141 is a NA clinical trial of X ray imaging in Tin X Ray, sponsored by Ramsay Générale de Santé.

Who is sponsoring NCT04119141?

NCT04119141 is sponsored by Ramsay Générale de Santé.

What drugs are being tested in NCT04119141?

Interventions in NCT04119141: X ray imaging.

What condition does NCT04119141 study?

NCT04119141 studies Tin X Ray, Pulmonary Parenchyma.

Is NCT04119141 still recruiting?

NCT04119141 is currently status unknown. Last updated 8 October 2019.

Last reviewed 2019-10-08 · How we verify

NCT04119141

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Benefit of Tin Filter in Regards to Image Quality and Radiation Dose in CT Scan Study of Pulmonary Parenchyma

Status unknown NA Last updated 8 October 2019

What this trial tests

NA trial testing X ray imaging in Tin X Ray in 25 participants. Status unknown.

Timeline

10 May 2019

Primary endpoint
30 June 2020

30 June 2020

Quick facts

Lead sponsor	Ramsay Générale de Santé
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	device feasibility
Enrollment	25
Start date	10 May 2019
Primary completion	30 June 2020
Estimated completion	30 June 2020
Sites	1 location across France

Drugs / interventions tested

X ray imaging

Conditions studied

Tin X Ray — all drugs for Tin X Ray →
Pulmonary Parenchyma — all drugs for Pulmonary Parenchyma →

Sponsor

Ramsay Générale de Santé — full company profile →

Who can join

18 and older, any sex, with Tin X Ray or Pulmonary Parenchyma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Main objective: to demonstrate that the diagnostic quality associated with the acquisition mode with tin filter, evaluated in a subjective way, is not inferior to that associated with the acquisition mode without filter.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ramsay Générale de Santé trials

Trials by the same sponsor.

NCT07353060 — Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT) · NA · not yet recruiting
NCT07245823 — Randomized Study Evaluating the Treatment of Vulvovaginal Gaping by Plication of the Puborectalis Muscles Versus Perineo · NA · recruiting
NCT07142330 — Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries · not yet recruiting
NCT07203131 — Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Ca · NA · recruiting
NCT07469007 — Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04119141 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ramsay Générale de Santé
Last refreshed: 8 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04119141.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing